Purpose: Cationic polymers are widely studied non-viral gene vectors but generally show lower transfection efficiency than viral vectors. Endosomal escape is a major bottleneck. Histidine/imidazole-containing polymers can enhance gene expression via a “proton sponge” effect without increasing toxicity. Polyphosphazenes are biodegradable and versatile, but few derivatives have been explored for gene delivery. A new histidylated cationic polyphosphazene was developed to improve transfection with low cytotoxicity.
Hypothesis: If histidine moiety (His(Boc)-OMe) and 2-dimethylaminoethylamine (DMAEA) are incorporated as side groups into a cationic polyorganophosphazene, then the resulting polymer (PDHP) will self-assemble with DNA into nanoparticles that mediate higher transfection efficiency and lower cytotoxicity than PDAP and PEI 25, due to the imidazole group’s endosomal buffering capacity.
Aims: Synthesize and characterize poly(DMAEA/His(Boc)-OMe)phosphazene (PDHP). - Prepare and characterize PDHP/DNA self-assembled nanoparticles (PHSNs). - Evaluate cytotoxicity of PDHP in 293T cells compared with PDAP and PEI 25. - Assess in vitro transfection efficiency of PHSNs and compare with PDAP/DNA (PASNs) and PEI 25/DNA (PESNs).
Delivery system:
Component: Polymer; Details: Poly(DMAEA/His(Boc)-OMe)phosphazene (PDHP); cationic polyorganophosphazene
Component: Side groups; Details: DMAEA (2-dimethylaminoethylamine) and His(Boc)-OMe; approximate molar ratio His(Boc)-OMe:DMAEA = 0.4:1.6
Component: Payload; Details: pEGFP-N1 plasmid DNA (4.7 kb, EGFP reporter)
Component: Nanoparticle formation; Details: Electrostatic self-assembly; PDHP/DNA ratios tested 0.5:1 to 20:1 (w/w)
Component: Size / charge; Details: ~110 nm and +15 mV at 10:1 (w/w); sizes 100–130 nm at ratios ≥1:1; zeta potential increased from 0.81 to 27 mV from 1:1 to 20:1
Component: Targeting ligand; Details: None
Component: Controls; Details: PDAP/DNA (PASNs) and PEI 25/DNA (PESNs)
Approach: In vitro only. No in vivo studies. - Cell line: 293T human embryonic kidney cells. - Cytotoxicity: MTT assay; polymer concentrations 5, 25, 50, 100, 200 µg/mL; 4 h incubation in serum-free DMEM. - Transfection: 2.5 µg DNA per well; polymer/DNA ratios 1:1 to 20:1; 4 h in serum-free DMEM, then 48 h in growth medium; EGFP expression measured by FACS and fluorescence microscopy. - Replicates: Triplicate samples; statistical analysis by Student’s t-test (p < 0.05).
Key methods: Polymer characterization: ¹H NMR, ³¹P NMR, GPC. - Nanoparticle characterization: Gel retardation assay, particle size and zeta potential (Nicomp 380/ZLS). - Cytotoxicity: MTT assay. - Transfection efficiency: FACS Calibur for EGFP fluorescence intensity; fluorescence microscopy for visual confirmation.
Key results: Polymer: PDHP Mw = 17.1 kDa, Mn = 15.2 kDa; ³¹P NMR showed signals for -NP(DMAEA)₂ and -NP(DMAEA/His(Boc)-OMe). - Nanoparticles: PHSNs size ~110 nm at 10:1; zeta +15 mV at 10:1. DNA fully retarded at PDHP/DNA ≥1:1. - Cytotoxicity: PDHP cell viability ~77% at 50 µg/mL, vs PDAP 41% and PEI 25 30%. PHSNs viability >85% at ratios ≤10:1; dropped to 66% at 20:1. - Transfection: Optimal at PDHP/DNA 10:1; maximum at 25 µg PDHP with 2.5 µg DNA per well. PDHP at 10:1 produced much higher EGFP expression than PASNs and PESNs. Naked DNA showed minimal expression. - Ratio effect: Transfection decreased at 5:1 and 20:1, likely due to insufficient charge/imidazole or increased cytotoxicity, respectively.
Interpretation: The authors claim that PDHP is a promising cationic polymer for gene delivery, offering high transfection efficiency and much lower cytotoxicity than PDAP and PEI 25. The histidine moiety is thought to enhance endosomal escape via the proton sponge effect. Further studies are suggested to evaluate in vivo transfection efficiency.
Limitations: In vitro only: No in vivo validation, biodistribution, or therapeutic efficacy. - Single cell line: 293T cells only; generalizability to primary or disease-relevant cells not established. - Serum-free transfection: Transfections performed in serum-free DMEM; serum stability not assessed. - No targeting ligand: Delivery relies on nonspecific electrostatic interactions. - No mechanistic proof: Proton sponge/endosomal escape mechanism inferred, not directly visualized. - Cytotoxicity at high ratios: Viability dropped to 66% at 20:1. - No long-term expression or safety data. - No comparison with viral vectors. - Small-scale study: n = 3; no in vivo dose–response.
